Nilubol, Naris <br/><br/>
Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors.  [electronic resource] 

 -  Journal of the National Cancer Institute  09 2018 
 - 1019-1029 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djy003  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Capillary Permeability--drug effects<br/>Cell Line, Tumor<br/>Disease Models, Animal<br/>Endothelium, Vascular--drug effects<br/>Gene Expression<br/>Gene Expression Profiling<br/>Gold--pharmacology<br/>Humans<br/>Mice<br/>Mice, Knockout<br/>Molecular Targeted Therapy<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Neovascularization, Pathologic--therapy<br/>Neuroendocrine Tumors--genetics<br/>Pancreatic Neoplasms--genetics<br/>Polyethylene Glycols--pharmacology<br/>Recombinant Proteins<br/>Theranostic Nanomedicine<br/>Thyroid Neoplasms--genetics<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Xenograft Model Antitumor Assays